医学知识

订阅

MedSci主页 / 所有栏目 / 医学知识

SCI写作之方法

2018-04-11 MedSci MedSci原创

科研基金
关注

科研基金

SCI写作之方法






评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1649734, encodeId=ce0e1649e34bd, content=<a href='/topic/show?id=35fb160183f' target=_blank style='color:#2F92EE;'>#SCI写作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16018, encryptionId=35fb160183f, topicName=SCI写作)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecf423907717, createdName=xlwang2699, createdTime=Thu Nov 29 10:13:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1279602, encodeId=d9d012e96023d, content=<a href='/topic/show?id=ab1430e146e' target=_blank style='color:#2F92EE;'>#写作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30714, encryptionId=ab1430e146e, topicName=写作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Fri Apr 13 05:13:00 CST 2018, time=2018-04-13, status=1, ipAttribution=)]
    2018-11-29 xlwang2699

    #SCI写作#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1649734, encodeId=ce0e1649e34bd, content=<a href='/topic/show?id=35fb160183f' target=_blank style='color:#2F92EE;'>#SCI写作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16018, encryptionId=35fb160183f, topicName=SCI写作)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecf423907717, createdName=xlwang2699, createdTime=Thu Nov 29 10:13:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1279602, encodeId=d9d012e96023d, content=<a href='/topic/show?id=ab1430e146e' target=_blank style='color:#2F92EE;'>#写作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30714, encryptionId=ab1430e146e, topicName=写作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Fri Apr 13 05:13:00 CST 2018, time=2018-04-13, status=1, ipAttribution=)]
    2018-04-13 chenhongpeng

    #写作#

    0

相关资讯

目标期刊选择

目标期刊选择

SCI写作之结果

SCI写作之结果图1.RCT研究患者招募流程图 图2.基线资料表图3.疗效表格图4.安全性表格图5.患者招募流程图RCT研究的结局有主要终点和次要终点之分，研究终点有几种形式，见下表

研究基础与工作条件的展示

研究基础与工作条件的展示

审稿意见分析

审稿意见分析

SCI写作之题目与摘要

SCI写作之题目与摘要

SCI写作之讨论

SCI写作之讨论